These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Squamous Cell Carcinoma AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
519 results:

  • 1. Can Hounsfield unit density value accurately predict prelaryngeal invasion in laryngeal carcinoma cases.
    Dizdar SK; Salepci E; Ağrıdağ B; Seyhun N; Gemalmaz A; Turgut S
    Auris Nasus Larynx; 2024 Aug; 51(4):803-810. PubMed ID: 38964030
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The rapidly changing field of predictive biomarkers of non-small cell lung cancer.
    Tóth LJ; Mokánszki A; Méhes G
    Pathol Oncol Res; 2024; 30():1611733. PubMed ID: 38953007
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases.
    Suster DI; Ronen N; Mejbel HA; Harada S; Mackinnon AC; Suster S
    Virchows Arch; 2024 Jul; 485(1):83-96. PubMed ID: 38814477
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands.
    de Jager VD; Cajiao Garcia BN; Kuijpers CCHJ; de Bock GH; Maas WJ; Timens W; van Kempen LC; van der Wekken AJ; Schuuring E; Willems SM
    Eur J Cancer; 2024 Jul; 205():114125. PubMed ID: 38788285
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary squamous cell carcinoma of the Thyroid Has a Molecular Genetic Profile Distinct From That of Anaplastic Thyroid carcinoma: A Whole Exome Sequencing and Gene Expression Profiling Study.
    Ye M; Guo Z; Xu J; Jin Y; He X; Ge M
    Am J Surg Pathol; 2024 Aug; 48(8):1024-1031. PubMed ID: 38775423
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer cell Lines Regardless of HPV Status.
    Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
    Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Frequency of braf V600E immunoexpression in ameloblastomas: a multi-institutional analysis of 86 cases in Latin America and comprehensive review of the literature.
    Silveira FM; Schuch LF; Pereira-Prado V; Sicco E; Almeda-Ojeda O; Molina-Frechero N; Paparella ML; Villarroel-Dorrego M; Hernadez M; Bologna-Molina R
    Med Oral Patol Oral Cir Bucal; 2024 Jul; 29(4):e509-e516. PubMed ID: 38615253
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Challenging pitfalls in frozen section pathology: a case of mandible ghost cell odontogenic carcinoma and the literature review.
    Hu SS; Yang J; Zhang HF; Chen J; Li XN; Liu FJ; Wang B
    BMC Oral Health; 2024 Apr; 24(1):450. PubMed ID: 38614992
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Considerable interlaboratory variation in PD-L1 positivity for head and neck squamous cell carcinoma in the Netherlands- A nationwide evaluation study.
    Hempenius MA; Koomen BM; Deckers IAG; Oosting SF; Willems SM; van der Vegt B
    Histopathology; 2024 Jul; 85(1):133-142. PubMed ID: 38606992
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
    Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
    [No Abstract]    [Full Text] [Related]  

  • 11. PD-L1 expression and its correlation with clinicopathological and molecular characteristics in Chinese patients with non-small cell lung cancer.
    Guo J; Yuan H; Zhu Y; Che Z; Zhang B; Zhang D; Zhou Y; Xiong L
    Medicine (Baltimore); 2024 Feb; 103(8):e36770. PubMed ID: 38394518
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
    Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
    Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck squamous cell carcinoma.
    Huang J; Xu Z; Wang Z; Zhou C; Shen Y
    Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Ubiquitination, SUMOylation, and NEDDylation related genes serve as prognostic and therapeutic biomarkers for oral squamous cell carcinoma.
    Deng SZ; Wu X; Kong L; Cheng B; Dai L
    J Oral Pathol Med; 2024 Feb; 53(2):114-123. PubMed ID: 38234119
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Very rare tumour of the palatine tonsil: a molecular approach.
    Ramael M; Van Steelandt H; Puls T; Ramael M
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38216164
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Factors influencing receipt and time to treatment of immunotherapy relative to chemotherapy in stage III and stage IV melanoma.
    Dhaliwal GS; Shahin AB; Lim ES; Mi L; Mangold AR; Swanson DL; Costello CM
    Cancer Med; 2024 Jan; 13(1):e6888. PubMed ID: 38186321
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small cell Lung Cancer.
    Sakamoto T; Matsubara T; Takahama T; Yokoyama T; Nakamura A; Tokito T; Okamoto T; Akamatsu H; Oki M; Sato Y; Tobino K; Ikeda S; Mori M; Mimura C; Maeno K; Miura S; Harada T; Nishimura K; Hiraoka M; Kenmotsu H; Fujimoto J; Shimokawa M; Yamamoto N; Nakagawa K
    JAMA Netw Open; 2023 Dec; 6(12):e2347700. PubMed ID: 38100106
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
    Aggarwal A; Sharma S; Brar Z; Kumar V; Kumar A; Katara R; Mohanty SK
    Pathol Res Pract; 2024 Jan; 253():155013. PubMed ID: 38096714
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Circulating lung cancer biomarkers: From translational research to clinical practice.
    Qian X; Meng QH
    Tumour Biol; 2024; 46(s1):S27-S33. PubMed ID: 37927289
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Study of genetic variants in 169 non-small cell lung cancer patients].
    Formanti Alonso L; Atienza Cuevas L; Romero García R; Mohigefer Barrera J; Del Río Ignacio JJ; Santisteban Espejo A; Bernal Florindo I; Catalina Fernández I; García Rojo M
    Rev Esp Patol; 2023; 56(4):233-242. PubMed ID: 37879820
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 26.